Concepedia
Statistics
Publications
6
Citations
279
H-Index
Active since
2015
Affiliations
Vanderbilt University Medical Center(Current)
James Madison University
Vanderbilt University
Center for Cancer Research
Michael Rudloff is an author at Vanderbilt University Medical Center specializing in oncology, life sciences, and cancer cell signaling.
Publications per year
2015–2023
Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division
Michael Rudloff, Paul Zumbo, Natalie R. Favret et al. · Nature Immunology · 2023 · 128 citations · Full text
Life Sciences, Immunology, Oncology +16
Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases
Leela Rani Avula, Michael Rudloff, Salma El-Behaedi et al. · Molecular Cancer Research · 2019 · 52 citations · Full text
Medicine, Cancer Biology, Oncology +7
Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway
Maegen A. Ackermann, Brendan King, Nicole A. P. Lieberman et al. · Journal of Molecular and Cellular Cardiology · 2017 · 33 citations
Life Sciences, Cell Biology, Molecular Biology +12
Biophysical characterization of naturally occurring titin M10 mutations
Michael Rudloff, Alec N. Woosley, Nathan T. Wright · Protein Science · 2015 · 27 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes
Emily Kolyvas, Michael Rudloff, Marianne S. Poruchynsky et al. · Oncotarget · 2016 · 26 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 6